<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Silent <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> (SBI) in the penetrating arteries is thought to be one of risk factors for overt cerebral <z:hpo ids='HP_0001297'>stroke</z:hpo> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Although both Lp(a) concentration and apo(a) phenotype have been reported as risk factors for atherothrombotic infarction in cortical arteries, the roles of Lp(a) in the pathogenesis of <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> in the penetrating arteries remains controversial </plain></SENT>
<SENT sid="2" pm="."><plain>We assessed the importance of apo(a) phenotype as a risk for SBI using a case control analysis </plain></SENT>
<SENT sid="3" pm="."><plain>The frequency of low molecular weight phenotype (allele a) of apo(a) was significantly higher in subjects with SBI than in those without SBI </plain></SENT>
<SENT sid="4" pm="."><plain>Relative risk for SBI was significantly higher in subjects with allele a than in subjects without allele a </plain></SENT>
<SENT sid="5" pm="."><plain>Apo(a) phenotype was indicated to be one of the risk factors for SBI </plain></SENT>
</text></document>